# Exploring Deleterious Nonsynonymous SNPs in the ACADM Gene: Insights Into Medium‐Chain Acyl‐CoA Dehydrogenase Deficiency (MCADD) via In Silico Analysis

## TL;DR

This study uses computer-based methods to analyze harmful genetic variations in the ACADM gene linked to a severe metabolic disorder called MCADD.

## Contribution

The study identifies two harmful nonsynonymous SNPs in the ACADM gene and evaluates their impact on protein stability and function using in silico techniques.

## Key findings

- Two nsSNPs, rs121434282 and rs200724875, significantly affect the structure and function of the ACADM protein.
- Molecular docking and dynamics simulations confirmed the destabilizing effect of these SNPs on the protein.
- ACADM is involved in multiple cellular pathways and co-expression networks, highlighting its functional importance.

## Abstract

Medium‐chain acyl‐CoA dehydrogenase deficiency (MCADD), a potentially lethal metabolic disorder, is often associated with single‐nucleotide polymorphisms (SNPs) in the acyl‐CoA dehydrogenase, medium‐chain (ACADM) gene. The current research investigates the structural and functional implications of these genetic variants through diverse bioinformatics techniques. A range of in silico techniques were utilized to thoroughly evaluate the effect of nonsynonymous SNPs. Molecular docking and molecular dynamics simulation evaluation comprehensively validated the mutational impact on protein’s stability. Gene interaction analysis demonstrated that ACADM is involved in several cellular pathways and co‐expression networks. Two nsSNPs, rs121434282 and rs200724875, were found to have a significant impact on the composition and functionality of ACADM. This research lays the foundation for precision medicine advancements, specifically against metabolic disorders. Thorough validation of the proposed nsSNPs, supported by animal models, is crucial for understanding their role in MCADD.